To release chronic and
discomfort pain and
to get patients' and
their family's smile back

About AlphaNavi Pharma

Our mission to get patients' and their family's smiles back through the research & development of innovative novel drugs

News

2023/03/01
- Press release
Series B Round of Financing
AlphaNavi Pharma Inc. (“AlphaNavi”) (Head Office: Osaka, Japan; President and CEO: Yoshihiro Oyamada) announce …
2021/05/11
- information
AlphaNavi Pharma Inc., Announces Initiation of a Phase 1/2 Clinical Trial of ANP-230 in Patients with Familial Infantile Episodic Limb Pain
AlphaNavi Pharma Inc. (Headquarter: Sakyo-ku, Kyoto, Japan; CEO: Yoshihiro Oyamada) today announced the initia …
2020/06/05
- information
AlphaNavi Pharma Inc., was introduced in the case study of leading university-originated venture businesses’ efforts for team building, published by the Ministry of Economy, Trade, and Industry.
AlphaNavi Pharma Inc., (Head Office: Kyoto, Japan; CEO: Yoshihiro Oyamada), which is a start-up company to dev …